HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

starch polycaprolactone

a biodegradable material

Also Known As:

SPCL polymer

Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Hu, Hang: 1 article (12/2017)
2.	Li, Yihui: 1 article (12/2017)
3.	Li, Zifu: 1 article (12/2017)
4.	Tang, Yuxiang: 1 article (12/2017)
5.	Wu, Honglian: 1 article (12/2017)
6.	Xiao, Chen: 1 article (12/2017)
7.	Yang, Xiangliang: 1 article (12/2017)
8.	Yu, Chan: 1 article (12/2017)
9.	Zhou, Qing: 1 article (12/2017)
10.	Pires, Ana O: 1 article (02/2012)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2023 - "Herein, we reported that doxorubicin (Dox) and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles (DEPH NPs) eliminated CSCs and cancer cells by regulating redox status. " 12/06/2017 - "Templating from galactose-functionalized hydroxyethyl starch-polycaprolactone (Gal-HES-PCL) nanoparticles-stabilized Pickering emulsions, the resultant DOX/ICG@Gal-HES-PCL NCs had a diameter of around 140 nm and showed an outstanding tumor-targeting ability, preferable tumor penetration capability, and promotion of photothermal effect. " 01/01/2023 - "Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy."
2.	Spinal Cord Injuries (Spinal Cord Injury) 02/01/2012 - "Interactions between Schwann and olfactory ensheathing cells with a starch/polycaprolactone scaffold aimed at spinal cord injury repair."

Related Drugs and Biologics

1.	Doxorubicin (Adriamycin)
2.	erastin
3.	Galactose (Galactopyranose)
4.	Emulsions

Related Therapies and Procedures

1.	Therapeutics